Urinalysis Market by Product (Consumables [Disposable, Reagents], Instruments [Automated, Microscopy, PoC]), Test Type (Pregnancy, Sediment), Application (UTI, Diabetes, CKD), Technology (Biochemical), End User (Hospital) & Region -Global Forecast to 2031

Market Size
$4.88B
MARKET SIZE, 2026
Projected Market Size
$7.16B
MARKET SIZE, 2031
CAGR
8.0%
CAGR (2026-2031)
Forecast Period
2026-2031
FORECAST PERIOD

URINALYSIS MARKET SIZE, SHARE & GROWTH SNAPSHOT

urinalysis-systems-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global urinalysis market is projected to grow from USD 4.88 billion in 2026 to USD 7.16 billion by 2031, at a CAGR of 8.0% during the forecast period. The market was valued at USD 4.56 billion in 2025. Market growth is primarily driven by the rising prevalence of urinary tract infections (UTIs), diabetes, and kidney and liver diseases, along with an expanding geriatric population and the associated rise in age-related disorders. The growing adoption of point-of-care (PoC) diagnostic testing is also supporting market expansion by enabling faster, more accessible testing. Furthermore, increasing awareness of preventive healthcare and rising healthcare expenditure, particularly in emerging economies, are encouraging investments in advanced urinalysis products and diagnostic infrastructure. However, the availability of refurbished urine analyzers may limit market growth to some extent.

KEY TAKEAWAYS

  • MARKET SNAPSHOT:
    Base Year Market Size (2025): USD 4.56 Billion
    Current Market Size (2026): USD 4.88 Billion
    Forecast Market Size (2031): USD 7.16 Billion
    CAGR (2026–2031): 8.0%
  • SEGMENT LEADERSHIP:
    Regional Leader: Asia Pacific is expected to register the fastest growth in the urinalysis market during the forecast period.
    Product Leader: Consumables segment accounted for the largest market share of 72.5% in 2025.
    Test Type Leader: Pregnancy & fertility tests segment accounted for the largest market share of 42.8% in 2025.
    Application Leader: Disease screening segment accounted for the largest market share in 2025.
    Technology Leader: Digital microscopy segment is projected to grow fastest during the forecast period.
    End User Leader: Hospitals & clinics segment is expected to register the highest CAGR in the urinalysis market during the forecast period.
  • MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
    Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Cardinal Health, Danaher Corporation, and Abbott were identified as star players, and are supported by their strong market presence and extensive product portfolios.
    High Technology Inc., Agappe Diagnostic Ltd., and Dialab GmbH have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas.

The urinalysis market is driven by the rising prevalence of UTIs, diabetes, and kidney and liver diseases, along with the growing geriatric population and the adoption of point-of-care (PoC) testing. Increasing awareness of preventive healthcare and rising healthcare expenditure, particularly in emerging economies, are further supporting investment in advanced urinalysis products and infrastructure. However, the availability of refurbished urine analyzers may restrain market growth to some extent.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The urinalysis market is driven by the rising prevalence of urinary tract infections (UTIs), diabetes, and kidney and liver disorders. Growing awareness of preventive healthcare and the adoption of point-of-care testing are expected to shape the revenue mix of urinalysis product manufacturers. In addition, research laboratories and academic institutions contribute to market growth through collaborations with diagnostic technology providers. These institutions use urinalysis technologies to advance research into disease mechanisms, diagnostic methods, and clinical applications. Such collaborations support technology development, facilitate innovation, and broaden the potential applications of urinalysis products.

urinalysis-systems-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer
  • Rising geriatric population and subsequent increase in age-associated diseases
RESTRAINTS
Impact
Level
  • Availability of refurbished urine analyzers
  • High capital investments and lack of skilled laboratory technicians
OPPORTUNITIES
Impact
Level
  • Growth opportunities in emerging countries
  • Technological advancements in urine analyzers
CHALLENGES
Impact
Level
  • Changing regulatory landscape

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer

The rising prevalence of urinary tract infections (UTIs), diabetes, kidney and liver diseases, and bladder cancer is driving demand for urinalysis. As these conditions become more common, the need for early diagnosis, routine screening, and ongoing disease monitoring is growing. Urinalysis plays a key role in detecting and monitoring several of these conditions. In addition, chronic diseases such as diabetes can lead to kidney complications, further increasing the need for regular urinalysis. Technological advances in automated analyzers and point-of-care testing are improving the accuracy, speed, and convenience of urine testing across clinical and home care settings.

Restraint: High capital investments and lack of skilled laboratory technicians

The increasing demand for diagnostic testing is being challenged by a shortage of skilled laboratory staff in many developed and developing nations. This gap is driven by factors such as a larger patient population, retiring experienced technicians, and a scarcity of trained laboratory professionals. Moreover, strict education and certification standards in certain countries can restrict the pool of qualified personnel. This skilled technician shortage may hinder the smooth functioning of advanced urinalysis systems and slow market growth, especially in healthcare environments with limited resources.

Opportunity: Technological advancements in urine analyzers

The urinalysis field has witnessed significant technological advancements, evolving from visual inspection of test strips to automated systems capable of performing biochemical analysis, sediment analysis, flow cytometry, and digital microscopy. Automated urine analyzers enable faster processing, reduce manual intervention, improve testing consistency, and support higher testing volumes. The increasing adoption of integrated and automated urinalysis systems presents significant opportunities for manufacturers to improve laboratory efficiency and expand the use of advanced urine testing technologies.

Challenge: Changing regulatory landscape

Regulatory requirements for in vitro diagnostic (IVD) products, including urinalysis systems and consumables, are becoming increasingly stringent across major markets such as the US and Europe. Manufacturers must comply with evolving requirements for product classification, performance evaluation, quality systems, labeling, and market authorization. In the US, certain IVD products may require FDA review, including 510(k) clearance, depending on their classification and intended use. The EU has implemented more stringent requirements under the In Vitro Diagnostic Medical Devices Regulation (IVDR). These evolving requirements can increase compliance costs, extend product development timelines, and create challenges for market participants.

URINALYSIS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
 Automated and semi-automated urine analyzers, urine chemistry reagents, consumables High-throughput testing, accurate and reliable results, streamlined workflow, supports early disease detection and monitoring
company logo
 Urine analyzers and consumables for clinical and home testing Rapid and precise testing, user-friendly interface, efficient workflow integration, supports home and clinical testing
company logo
 Urinalysis reagents, dipsticks, consumables, point-of-care testing solutions Reliable routine testing, cost-effective solutions, broad product range for hospitals and labs, supports chronic disease monitoring
company logo
 Automated urine chemistry analyzers and consumables High-volume automated testing, improved accuracy and consistency, reduces operator error, suitable for large diagnostic labs
company logo
 Point-of-care urine analyzers and consumables Rapid point-of-care results, convenient and portable testing, supports clinical decision-making in hospitals and remote settings

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The urinalysis market ecosystem comprises key stakeholders and activities involved in the development, supply, adoption, and regulation of urinalysis products. It includes consumables and instruments, along with their applications across healthcare settings. Manufacturers are responsible for research, product development, technology advancement, and the commercialization of urinalysis solutions. Distributors, including third-party vendors and e-commerce platforms, support product marketing, distribution, and supply to end users. Research and development activities are conducted by in-house R&D teams, contract research organizations (CROs), and contract development and manufacturing organizations (CDMOs) that provide specialized services for product development and manufacturing. End users, including diagnostic laboratories, hospitals and clinics, home care settings, and research laboratories, are key stakeholders that use urinalysis products for diagnostic and monitoring purposes. In addition, investors, funding organizations, and regulatory authorities influence market development by supporting innovation, investment, and regulatory compliance.

urinalysis-systems-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

urinalysis-systems-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Urinalysis Market, By Product

By product, the urinalysis market is segmented into consumables and instruments. The consumables segment holds the largest market share, driven by the recurring use and frequent replacement of products such as test kits, dipsticks, reagents, and disposables. Hospitals, clinics, and diagnostic laboratories require a continuous supply of these products for routine urine testing, and the growing burden of chronic conditions such as diabetes and kidney diseases further supports recurring demand.

Urinalysis Market, By Test Type

By test type, the urinalysis market is segmented into biochemical tests, sediment urinalysis, and pregnancy & fertility tests. The pregnancy & fertility tests segment accounts for the largest market share, supported by rising awareness of reproductive health and family planning, as well as the convenience, accessibility, and rapid results of home-based testing. Biochemical tests and sediment urinalysis also play an important role in detecting and monitoring UTIs, kidney diseases, diabetes, and other health conditions, supporting continued demand for these testing methods.

Urinalysis Market, By Application

By application, the urinalysis market is segmented into disease screening and pregnancy and fertility testing. The disease screening segment holds the largest market share, driven by the rising prevalence of urinary tract infections (UTIs), kidney and liver diseases, diabetes, and other chronic conditions. Growing emphasis on early disease detection, routine health screening, and disease monitoring is driving urinalysis adoption across healthcare settings. Pregnancy and fertility testing also continues to contribute to market demand, particularly through the increasing adoption of convenient home-based diagnostic solutions.

Urinalysis Market, By Technology

By technology, the urinalysis market is segmented into biochemical assays, flow cytometry, digital microscopy, and other technologies. Biochemical assays hold the largest share, driven by their low cost, ease of use, and widespread use in disease screening, point-of-care diagnosis, and pregnancy testing. Flow cytometry and digital microscopy are gaining traction in diagnostic laboratories as demand for automated, high-throughput sediment analysis rises. Other technologies, including molecular diagnostics and biosensors, are seeing steady adoption for rapid pathogen identification and point-of-care applications.

Urinalysis Market, By End User

By end user, the urinalysis market is segmented into diagnostic laboratories, hospitals and clinics, home care settings, and research laboratories and institutes. Diagnostic laboratories account for the largest market share due to their high testing volumes and their role in supporting hospitals, clinics, physicians, and other healthcare providers. Increasing demand for routine disease screening, diagnosis, and monitoring, along with the adoption of automated urinalysis systems, supports the use of these products in diagnostic laboratories. Hospitals and clinics, home care settings, and research laboratories and institutes also contribute to market demand through routine testing, decentralized diagnostics, and research applications.

REGION

Asia Pacific to be fastest-growing region in global urinalysis market during forecast period

Asia Pacific is expected to post the highest CAGR in the urinalysis market over the forecast period, driven by expanding healthcare and diagnostic laboratory infrastructure, rising healthcare spending, and growing adoption of advanced diagnostic technologies. Countries such as China, India, Japan, and South Korea are seeing continued investment in healthcare modernization, laboratory automation, and diagnostic capabilities. Additionally, the rising prevalence of diabetes, kidney diseases, urinary tract infections (UTIs), and other chronic conditions, along with a growing geriatric population, is increasing demand for routine urine testing across the region. Growing awareness of preventive healthcare, early disease detection, and point-of-care testing is further supporting the adoption of urinalysis products in Asia Pacific.

urinalysis-systems-market Region

URINALYSIS MARKET: COMPANY EVALUATION MATRIX

In the urinalysis market, Siemens Healthineers AG (Germany) is recognized as a dominant player (Star), supported by its comprehensive urinalysis portfolio, strong global presence, advanced automated urine analyzers, and established laboratory diagnostics capabilities. The company further strengthens its position with integrated, automated urinalysis solutions that support high-throughput testing and laboratory efficiency. In contrast, F. Hoffmann-La Roche Ltd. (Switzerland) is emerging as a key market participant, supported by its broad portfolio of urine analyzers and test strips, strong biochemical urinalysis capabilities, and global distribution network. Roche continues to strengthen its position through technological innovation, product development, automation, and the expansion of its diagnostic solutions across clinical laboratories and healthcare settings.

urinalysis-systems-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 4.56 Billion
Market Size in 2026 (Value) USD 4.88 Billion
Market Forecast in 2031 (Value) USD 7.16 Billion
Growth Rate CAGR of 8.0 % from 2026–2031
Years Considered 2024–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered Value (USD Million/Billion)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • By Product:
    • Consumables
    • and Instruments
  • By Test Type:
    • Biochemical Tests Sediment Urinalysis
    • Pregnancy & Fertility Tests
  • By Application:
    • Disease Screening
    • Pregnancy & Fertility Testing
  • By Technology:
    • Biochemical Assay
    • Flow Cytometry
    • Digital Microscopy
    • Other Technologies
  • By End User:
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Home Care Settings
    • Research Laboratories & Institutes
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa

WHAT IS IN IT FOR YOU: URINALYSIS MARKET REPORT CONTENT GUIDE

urinalysis-systems-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Country-wise analysis of the urinalysis market across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa Delivered detailed country-level market sizing, growth forecasts, and demand analysis across major regions, with assessment of disease burden, testing volumes, healthcare infrastructure, and demand for urinalysis instruments and consumables Incorporated country-specific analysis of UTI, diabetes, and kidney disease prevalence, healthcare expenditure, diagnostic infrastructure, testing capabilities, and regulatory environment to identify high-growth markets and investment opportunities
Market share analysis and competitive benchmarking of key urinalysis market companies Provided detailed competitive benchmarking and market share analysis of leading urinalysis companies based on product portfolio, installed base, geographic presence, technology capabilities, distribution reach, and strategic initiatives across automated analyzers, biochemical testing, sediment analysis, and consumables Expanded the competitive landscape by profiling leading and emerging players and assessing recent product launches, regulatory approvals, partnerships, acquisitions, geographic expansions, and technology innovations to evaluate future competitive positioning
Pricing analysis of urinalysis consumables and instruments Delivered country-wise pricing analysis of urinalysis instruments and consumables, including automated urine analyzers, test strips, reagents, pregnancy & fertility kits, and associated consumables, with pricing variations assessed by product type, supplier, and end user Incorporated country-level procurement and tender practices, distributor dynamics, instrument placement models, consumable utilization, and laboratory purchasing patterns to provide a comprehensive assessment of pricing trends and market accessibility across regions

RECENT DEVELOPMENTS

  • July 2026 : Beckman Coulter Diagnostics, a Danaher Corporation (US) company, launched the DxU 1800 System, a fully automated urinalysis solution combining a new urine chemistry analyzer and consumables with market-leading microscopy, designed to help laboratories meet rising diagnostic testing volumes.
  • March 2026 : Siemens Healthineers expanded access to modernized urinalysis testing through the Atellica LumIQ Analyzer, a portable, scalable point-of-care instrument manufactured at its Sudbury, UK facility. Announced on March 25, the system digitizes and automates interpretation of reagent strips and is designed to support earlier detection and monitoring of kidney disease, urinary tract infections, pregnancy, and diabetes closer to the patient. The development directly concerns a new/modernized urinalysis testing system and therefore qualifies under the fallback January–March 2026 window.
  • February 2026 : Waters Corporation (US) completed its acquisition of Becton, Dickinson and Company's (US) Biosciences & Diagnostic Solutions business through a Reverse Morris Trust transaction, valued at approximately USD 18.8 billion at closing.

 

Table of Contents

checkmarkExclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
39
2
EXECUTIVE SUMMARY
 
 
 
 
 
44
3
PREMIUM INSIGHTS
 
 
 
 
 
49
4
MARKET OVERVIEW
Capitalize on emerging markets and tech advancements in urine diagnostics amid aging population trends.
 
 
 
 
 
53
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
INCREASING BURDEN OF UTIS, DIABETES, LIVER & KIDNEY DISEASES, AND BLADDER CANCER
 
 
 
 
 
 
4.2.1.2
RISING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN AGE-ASSOCIATED DISEASES
 
 
 
 
 
 
4.2.1.3
INCREASING ADOPTION OF POC URINE DIAGNOSTIC TESTS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
AVAILABILITY OF REFURBISHED URINE ANALYZERS
 
 
 
 
 
 
4.2.2.2
HIGH CAPITAL INVESTMENTS AND LACK OF SKILLED LABORATORY TECHNICIANS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
GROWTH OPPORTUNITIES IN EMERGING COUNTRIES
 
 
 
 
 
 
4.2.3.2
TECHNOLOGICAL ADVANCEMENTS IN URINE ANALYZERS
 
 
 
 
 
 
4.2.3.3
INCREASING GOVERNMENT INITIATIVES AND FUNDING FOR PREVENTIVE CARE
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
CHANGING REGULATORY LANDSCAPE
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
 
 
4.3.1
UNMET NEEDS IN URINALYSIS DIAGNOSTICS MARKET
 
 
 
 
 
 
4.3.2
WHITE SPACE OPPORTUNITIES
 
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
 
4.4.1
INTERCONNECTED MARKETS
 
 
 
 
 
 
4.4.2
CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
 
 
 
 
 
 
 
4.5.1
KEY MOVES AND STRATEGIC FOCUS
 
 
 
 
5
INDUSTRY TRENDS
Navigate competitive pressures and economic shifts to leverage urinalysis market opportunities effectively.
 
 
 
 
 
65
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
THREAT OF NEW ENTRANTS
 
 
 
 
 
 
5.1.2
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.4
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
5.2
MACROECONOMIC INDICATORS
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
 
5.3
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
 
 
5.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
5.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
URINALYSIS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
 
 
 
 
 
5.6
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
AVERAGE SELLING PRICE OF URINALYSIS, BY KEY PLAYER, 2024–2026
 
 
 
 
 
 
5.6.2
AVERAGE SELLING PRICE OF URINALYSIS BY REGION, 2024–2026
 
 
 
 
 
5.7
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.7.1
IMPORT SCENARIO (HS CODE 3822)
 
 
 
 
 
 
5.7.2
EXPORT SCENARIO (HS CODE 3822)
 
 
 
 
 
5.8
KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
5.10
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFF ON URINALYSIS MARKET
 
 
 
 
 
 
 
 
5.11.1
INTRODUCTION
 
 
 
 
 
 
5.11.2
KEY TARIFF RATES
 
 
 
 
 
 
5.11.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.11.4
IMPACT ON REGION
 
 
 
 
 
 
 
5.11.4.1
NORTH AMERICA
 
 
 
 
 
 
5.11.4.2
EUROPE
 
 
 
 
 
 
5.11.4.3
ASIA PACIFIC
 
 
 
 
 
5.11.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
 
 
5.11.5.1
HOSPITALS & CLINICS
 
 
 
 
 
 
5.11.5.2
HOME CARE SETTINGS
 
 
 
 
 
 
5.11.5.3
DIAGNOSTIC LABORATORIES
 
 
 
6
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock market profitability by addressing unmet needs and overcoming adoption barriers in key industries.
 
 
 
 
 
84
 
6.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
6.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
6.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
6.2.2
BUYING CRITERIA
 
 
 
 
 
6.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
6.4
UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
 
 
 
 
 
 
6.5
MARKET PROFITABILITY
 
 
 
 
 
 
 
6.5.1
REVENUE POTENTIAL
 
 
 
 
 
 
6.5.2
COST DYNAMICS
 
 
 
 
 
 
6.5.3
MARGIN OPPORTUNITIES IN KEY APPLICATIONS/INDUSTRIES
 
 
 
 
7
REGULATORY LANDSCAPE AND SUSTAINABILITY
Navigate complex regulations and eco-initiatives driving sustainable urinalysis globally.
 
 
 
 
 
91
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
7.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
 
7.2.1
ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN URINALYSIS
 
 
 
 
 
 
 
7.2.1.1
ECO-FRIENDLY INITIATIVES
 
 
 
 
7.3
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
 
 
 
 
 
8
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven innovations revolutionize urinalysis with cutting-edge technologies and strategic patent advancements.
 
 
 
 
 
96
 
8.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
 
 
8.1.1
AUTOMATED URINE ANALYZERS
 
 
 
 
 
 
8.1.2
BIOCHEMICAL ASSAY
 
 
 
 
 
8.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
8.2.1
POINT-OF-CARE URINE ANALYZERS
 
 
 
 
 
8.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
8.3.1
MULTIPLEX PCR
 
 
 
 
 
8.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
8.5
PATENT ANALYSIS
 
 
 
 
 
 
 
 
8.5.1
LIST OF KEY PATENTS
 
 
 
 
 
8.6
FUTURE APPLICATIONS
 
 
 
 
 
 
8.7
IMPACT OF AI/GENERATIVE AI ON THE URINALYSIS MARKET
 
 
 
 
 
 
 
 
8.7.1
INTRODUCTION
 
 
 
 
 
 
8.7.2
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
8.7.3
KEY COMPANIES IMPLEMENTING AI
 
 
 
 
 
 
8.7.4
FUTURE OF AI/GEN AI
 
 
 
 
9
URINALYSIS MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 100 Data Tables
 
 
 
 
 
106
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
CONSUMABLES
 
 
 
 
 
 
 
9.2.1
PREGNANCY & FERTILITY KITS
 
 
 
 
 
 
 
9.2.1.1
RAPID ACCESSIBILITY AND TESTING CONVENIENCE TO DRIVE MARKET
 
 
 
 
 
9.2.2
DIPSTICKS
 
 
 
 
 
 
 
9.2.2.1
LOW COST TO INCREASE ADOPTION
 
 
 
 
 
9.2.3
REAGENTS
 
 
 
 
 
 
 
9.2.3.1
INCREASING USE OF CONTROLS AND CALIBRATORS TO DRIVE MARKET
 
 
 
 
 
9.2.4
DISPOSABLES
 
 
 
 
 
 
 
9.2.4.1
WISE USAGE IN HOSPITALS AND CLINICAL LABORATORIES TO SUPPORT MARKET GROWTH
 
 
 
 
9.3
INSTRUMENTS
 
 
 
 
 
 
 
9.3.1
AUTOMATED URINE ANALYZERS
 
 
 
 
 
 
 
9.3.1.1
INTEGRATED URINE ANALYZERS
 
 
 
 
 
 
 
 
9.3.1.1.1
HIGHER WORKLOAD IN HOSPITALS AND LABORATORIES TO INCREASE ADOPTION OF INTEGRATED URINE ANALYZERS
 
 
 
 
9.3.1.2
SEDIMENT URINE ANALYZERS
 
 
 
 
 
 
 
 
9.3.1.2.1
MICROSCOPY ANALYZERS
 
 
 
 
 
 
9.3.1.2.2
FLOW CYTOMETRY ANALYZERS
 
 
 
 
9.3.1.3
BIOCHEMICAL URINE ANALYZERS
 
 
 
 
 
 
 
 
9.3.1.3.1
INCREASING INCIDENCE OF KIDNEY DISEASES AND UTIS TO DRIVE MARKET
 
 
 
9.3.2
SEMI-AUTOMATED URINE ANALYZERS
 
 
 
 
 
 
 
9.3.2.1
EXTENSIVE USE IN HOSPITALS & CLINICS TO DRIVE SEGMENT GROWTH
 
 
 
 
 
9.3.3
POINT-OF-CARE URINE ANALYZERS
 
 
 
 
 
 
 
9.3.3.1
NEED FOR RAPID TESTING TO DRIVE DEMAND FOR POC URINE ANALYZERS
 
 
 
10
URINALYSIS MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 46 Data Tables
 
 
 
 
 
153
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
DISEASE SCREENING
 
 
 
 
 
 
 
10.2.1
URINARY TRACT INFECTIONS
 
 
 
 
 
 
 
10.2.1.1
INCREASING PREVALENCE OF UTIS TO DRIVE SEGMENT GROWTH
 
 
 
 
 
10.2.2
KIDNEY DISEASES
 
 
 
 
 
 
 
10.2.2.1
RAPIDLY GROWING GERIATRIC POPULATION AND INCREASING PREVALENCE OF KIDNEY DISEASES TO FUEL SEGMENT GROWTH
 
 
 
 
 
10.2.3
DIABETES
 
 
 
 
 
 
 
10.2.3.1
DEVELOPMENT OF ADVANCED ANALYTICAL TOOLS TO DRIVE MARKET
 
 
 
 
 
10.2.4
LIVER DISEASES
 
 
 
 
 
 
 
10.2.4.1
HIGH PREVALENCE OF LIVER DISEASES TO SUPPORT MARKET GROWTH
 
 
 
 
 
10.2.5
OTHER DISEASE SCREENING APPLICATIONS
 
 
 
 
 
10.3
PREGNANCY & FERTILITY TESTING
 
 
 
 
 
 
 
10.3.1
NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE SEGMENT
 
 
 
 
11
URINALYSIS MARKET, BY TEST TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 34 Data Tables
 
 
 
 
 
176
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
PREGNANCY & FERTILITY TESTS
 
 
 
 
 
 
 
11.2.1
RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE MARKET
 
 
 
 
 
11.3
BIOCHEMICAL TESTS
 
 
 
 
 
 
 
11.3.1
LABORATORY TESTS
 
 
 
 
 
 
 
11.3.1.1
GROWING INCIDENCE OF UTIS AND OTHER KIDNEY DISEASES TO DRIVE MARKET
 
 
 
 
 
11.3.2
POC TESTS
 
 
 
 
 
 
 
11.3.2.1
CONVENIENCE OF POC TESTING TO DRIVE SEGMENT GROWTH
 
 
 
 
11.4
SEDIMENT URINALYSIS
 
 
 
 
 
 
 
11.4.1
INCREASED ADOPTION OF AUTOMATED ANALYZERS TO DRIVE MARKET
 
 
 
 
12
URINALYSIS MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 25 Data Tables
 
 
 
 
 
193
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
BIOCHEMICAL ASSAY
 
 
 
 
 
 
 
12.2.1
WIDESPREAD USE ACROSS DISEASE SCREENING AND HOME-BASED TESTING TO SUPPORT SEGMENT DOMINANCE
 
 
 
 
 
12.3
FLOW CYTOMETRY
 
 
 
 
 
 
 
12.3.1
RISING ADOPTION OF AUTOMATED SEDIMENT ANALYSIS TO DRIVE STEADY GROWTH
 
 
 
 
 
12.4
DIGITAL MICROSCOPY
 
 
 
 
 
 
 
12.4.1
GROWING PREFERENCE FOR AI-ASSISTED IMAGING TO ACCELERATE ADOPTION
 
 
 
 
 
12.5
OTHER TECHNOLOGIES
 
 
 
 
 
13
URINALYSIS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 25 Data Tables
 
 
 
 
 
205
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
DIAGNOSTIC LABORATORIES
 
 
 
 
 
 
 
13.2.1
INCREASED OUTSOURCING OF DIAGNOSTIC TESTS BY HOSPITALS TO LABORATORIES TO AUGMENT MARKET
 
 
 
 
 
13.3
HOSPITALS & CLINICS
 
 
 
 
 
 
 
13.3.1
GROWING NUMBER OF HOSPITALS WORLDWIDE TO BOOST GROWTH
 
 
 
 
 
13.4
HOME CARE SETTINGS
 
 
 
 
 
 
 
13.4.1
INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO BOOST MARKET
 
 
 
 
 
13.5
RESEARCH LABORATORIES & INSTITUTES
 
 
 
 
 
 
 
13.5.1
DEVELOPMENT OF INNOVATIVE TESTS FOR DISEASE DETECTION TO FUEL MARKET
 
 
 
 
14
URINALYSIS MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 16 Countries | 287 Data Tables.
 
 
 
 
 
219
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
NORTH AMERICA
 
 
 
 
 
 
 
14.2.1
US
 
 
 
 
 
 
 
14.2.1.1
RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
 
 
 
 
 
14.2.2
CANADA
 
 
 
 
 
 
 
14.2.2.1
RISING BURDEN OF CKD TO AUGMENT MARKET
 
 
 
 
14.3
EUROPE
 
 
 
 
 
 
 
14.3.1
GERMANY
 
 
 
 
 
 
 
14.3.1.1
INCREASING HEALTHCARE EXPENDITURE TO FUEL MARKET GROWTH
 
 
 
 
 
14.3.2
UK
 
 
 
 
 
 
 
14.3.2.1
RISING GOVERNMENT HEALTHCARE EXPENDITURE TO PROPEL MARKET
 
 
 
 
 
14.3.3
FRANCE
 
 
 
 
 
 
 
14.3.3.1
HIGH R&D EXPENDITURE TO PROVIDE GROWTH OPPORTUNITIES
 
 
 
 
 
14.3.4
ITALY
 
 
 
 
 
 
 
14.3.4.1
RISING PREVALENCE OF DIABETES TO DRIVE MARKET
 
 
 
 
 
14.3.5
SPAIN
 
 
 
 
 
 
 
14.3.5.1
GROWING ELDERLY POPULATION TO PROPEL MARKET
 
 
 
 
 
14.3.6
REST OF EUROPE
 
 
 
 
 
14.4
ASIA PACIFIC
 
 
 
 
 
 
 
14.4.1
CHINA
 
 
 
 
 
 
 
14.4.1.1
IMPROVING HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
 
 
 
 
 
14.4.2
JAPAN
 
 
 
 
 
 
 
14.4.2.1
FAVORABLE REGULATORY FRAMEWORK TO DRIVE MARKET GROWTH
 
 
 
 
 
14.4.3
INDIA
 
 
 
 
 
 
 
14.4.3.1
INCREASING INVESTMENTS IN HEALTHCARE SYSTEM TO DRIVE MARKET
 
 
 
 
 
14.4.4
AUSTRALIA
 
 
 
 
 
 
 
14.4.4.1
RISING PREVALENCE OF CHRONIC DISEASES TO PROPEL MARKET
 
 
 
 
 
14.4.5
SOUTH KOREA
 
 
 
 
 
 
 
14.4.5.1
GROWING MEDICAL TOURISM TO DRIVE DEMAND FOR URINALYSIS
 
 
 
 
 
14.4.6
REST OF ASIA PACIFIC
 
 
 
 
 
14.5
LATIN AMERICA
 
 
 
 
 
 
 
14.5.1
BRAZIL
 
 
 
 
 
 
 
14.5.1.1
LARGEST HEALTHCARE MARKET IN LATIN AMERICA
 
 
 
 
 
14.5.2
MEXICO
 
 
 
 
 
 
 
14.5.2.1
POPULARITY IN MEDICAL TOURISM TO DRIVE MARKET GROWTH
 
 
 
 
 
14.5.3
REST OF LATIN AMERICA
 
 
 
 
 
14.6
MIDDLE EAST & AFRICA
 
 
 
 
 
 
 
14.6.1
UAE
 
 
 
 
 
 
 
14.6.1.1
HIGH DIABETES PREVALENCE TO DRIVE DEMAND FOR URINALYSIS
 
 
 
 
 
14.6.2
SAUDI ARABIA
 
 
 
 
 
 
 
14.6.2.1
RISING DIABETES BURDEN TO SUPPORT MARKET GROWTH
 
 
 
 
 
14.6.3
REST OF MIDDLE EAST & AFRICA
 
 
 
 
15
COMPETITIVE LANDSCAPE
Discover strategic moves and market dominance shaping the urinalysis industry's competitive landscape.
 
 
 
 
 
333
 
15.1
INTRODUCTION
 
 
 
 
 
 
15.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
 
 
15.2.1
OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN URINALYSIS MARKET
 
 
 
 
 
15.3
REVENUE ANALYSIS, 2023–2025
 
 
 
 
 
 
 
15.4
MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
 
 
15.4.1
GLOBAL MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
15.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
15.5.1
STARS
 
 
 
 
 
 
15.5.2
EMERGING LEADERS
 
 
 
 
 
 
15.5.3
PERVASIVE PLAYERS
 
 
 
 
 
 
15.5.4
PARTICIPANTS
 
 
 
 
 
 
15.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
15.5.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
15.5.5.2
REGION FOOTPRINT
 
 
 
 
 
 
15.5.5.3
PRODUCT FOOTPRINT
 
 
 
 
 
 
15.5.5.4
APPLICATION FOOTPRINT
 
 
 
 
15.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
 
15.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
15.6.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
15.6.3
DYNAMIC COMPANIES
 
 
 
 
 
 
15.6.4
STARTING BLOCKS
 
 
 
 
 
 
15.6.5
COMPANY FOOTPRINT: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
15.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
15.6.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY PRODUCT AND APPLICATION
 
 
 
 
 
 
15.6.5.3
COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION
 
 
 
 
15.7
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
 
 
15.7.1
FINANCIAL METRICS
 
 
 
 
 
 
15.7.2
COMPANY VALUATION
 
 
 
 
 
15.8
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
 
15.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
15.9.1
PRODUCT/SERVICE LAUNCHES & APPROVALS
 
 
 
 
 
 
15.9.2
DEALS
 
 
 
 
 
 
15.9.3
EXPANSIONS
 
 
 
 
16
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
352
 
16.1
KEY PLAYERS
 
 
 
 
 
 
 
16.1.1
SIEMENS HEALTHINEERS AG
 
 
 
 
 
 
 
16.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
16.1.1.2
PRODUCTS OFFERED
 
 
 
 
 
 
16.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
16.1.1.3.1
PRODUCT LAUNCHES
 
 
 
 
 
 
16.1.1.3.2
DEALS
 
 
 
 
 
 
16.1.1.3.3
EXPANSIONS
 
 
 
 
16.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
16.1.1.4.1
KEY STRENGTHS
 
 
 
 
 
 
16.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
16.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
 
 
 
16.1.2
F. HOFFMANN-LA ROCHE LTD
 
 
 
 
 
 
16.1.3
SYSMEX CORPORATION
 
 
 
 
 
 
16.1.4
DANAHER CORPORATION
 
 
 
 
 
 
16.1.5
ABBOTT
 
 
 
 
 
 
16.1.6
CARDINAL HEALTH, INC.
 
 
 
 
 
 
16.1.7
WATERS CORPORATION
 
 
 
 
 
 
16.1.8
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
 
 
16.1.9
BIO-RAD LABORATORIES, INC.
 
 
 
 
 
 
16.1.10
QUIDELORTHO CORPORATION
 
 
 
 
 
16.2
OTHER PLAYERS
 
 
 
 
 
 
 
16.2.1
ARKRAY, INC.
 
 
 
 
 
 
16.2.2
ACON LABORATORIES, INC.
 
 
 
 
 
 
16.2.3
77 ELEKTRONIKA KFT.
 
 
 
 
 
 
16.2.4
URIT MEDICAL ELECTRONIC CO., LTD.
 
 
 
 
 
 
16.2.5
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
 
 
 
 
 
 
16.2.6
DIRUI INDUSTRIAL CO., LTD.
 
 
 
 
 
 
16.2.7
BIOBASE GROUP
 
 
 
 
 
 
16.2.8
ERBA MANNHEIM
 
 
 
 
 
 
16.2.9
ALPHATEC SCIENTIFIC E.I.R.L.
 
 
 
 
 
 
16.2.10
TECO DIAGNOSTICS
 
 
 
 
 
 
16.2.11
ANALYTICON BIOTECHNOLOGIES GMBH
 
 
 
 
 
 
16.2.12
HIVIS MEDICAL TECHNOLOGY CO., LTD.
 
 
 
 
 
 
16.2.13
HIGH TECHNOLOGY, INC.
 
 
 
 
 
 
16.2.14
AGAPPE DIAGNOSTICS LTD
 
 
 
 
 
 
16.2.15
DIALAB GMBH
 
 
 
 
 
 
16.2.16
QUANTIMETRIX
 
 
 
 
 
 
16.2.17
BIOCARE CORPORATION
 
 
 
 
 
 
16.2.18
RANDOX LABORATORIES LTD.
 
 
 
 
 
 
16.2.19
PZ CORMAY S.A.
 
 
 
 
 
 
16.2.20
YD DIAGNOSTICS
 
 
 
 
 
 
16.2.21
CONTEC MEDICAL SYSTEMS CO., LTD.
 
 
 
 
 
 
16.2.22
CLARITY DIAGNOSTICS, LLC
 
 
 
 
 
 
16.2.23
BIOPANDA REAGENTS LTD.
 
 
 
 
 
 
16.2.24
GENUINE BIOSYSTEM
 
 
 
 
17
RESEARCH METHODOLOGY
 
 
 
 
 
403
 
17.1
RESEARCH DATA
 
 
 
 
 
 
17.2
RESEARCH APPROACH
 
 
 
 
 
 
 
17.2.1
SECONDARY DATA
 
 
 
 
 
 
 
17.2.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
17.2.2
PRIMARY DATA
 
 
 
 
 
 
 
17.2.2.1
LIST OF PRIMARY SOURCES
 
 
 
 
 
 
17.2.2.2
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
17.2.2.3
KEY INDUSTRY INSIGHTS
 
 
 
 
 
 
17.2.2.4
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
17.3
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
17.3.1
TOTAL MARKET SIZE: URINALYSIS MARKET
 
 
 
 
 
 
17.3.2
BOTTOM-UP APPROACH
 
 
 
 
 
 
 
17.3.2.1
APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
 
 
 
 
 
 
17.3.2.2
APPROACH 2: PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS
 
 
 
 
 
 
17.3.2.3
GROWTH FORECAST
 
 
 
 
 
 
17.3.2.4
CAGR PROJECTIONS
 
 
 
 
 
17.3.3
TOP-DOWN APPROACH
 
 
 
 
 
17.4
DATA TRIANGULATION
 
 
 
 
 
 
17.5
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
 
17.5.1
STUDY-RELATED ASSUMPTIONS
 
 
 
 
 
17.6
STUDY ASSUMPTIONS
 
 
 
 
 
 
 
17.6.1
PARAMETRIC ASSUMPTIONS
 
 
 
 
 
 
17.6.2
GROWTH RATE ASSUMPTIONS
 
 
 
 
 
17.7
RESEARCH LIMITATIONS
 
 
 
 
 
 
17.8
RISK ASSESSMENT
 
 
 
 
 
18
APPENDIX
 
 
 
 
 
416
 
18.1
DISCUSSION GUIDE
 
 
 
 
 
 
18.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
18.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
18.4
RELATED REPORTS
 
 
 
 
 
 
18.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
AGE-STANDARDIZED PREVALENCE OF DIABETES, % BY REGION, 2024 VS. 2050
 
 
 
 
 
 
TABLE 2
PERCENTAGE OF POPULATION AGED 65 YEARS OR OVER, BY REGION, 2030 VS. 2050
 
 
 
 
 
 
TABLE 3
URINALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
TABLE 4
GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023–2030
 
 
 
 
 
 
TABLE 5
NORTH AMERICA: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 6
EUROPE: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 7
ASIA PACIFIC: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 8
LATIN AMERICA: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 9
MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 10
AVERAGE SELLING PRICE OF URINALYSIS PRODUCTS, BY KEY PLAYER, 2024–2026 (USD)
 
 
 
 
 
 
TABLE 11
AVERAGE SELLING PRICE OF URINALYSIS PRODUCTS, BY REGION, 2024–2026 (USD)
 
 
 
 
 
 
TABLE 12
IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 13
EXPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 14
URINALYSIS MARKET: KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
 
 
TABLE 15
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 16
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT (%)
 
 
 
 
 
 
TABLE 17
KEY BUYING CRITERIA, BY PRODUCT
 
 
 
 
 
 
TABLE 18
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
TABLE 19
URINALYSIS MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
 
 
 
 
 
 
TABLE 20
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 21
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 22
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 23
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 24
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 25
KEY PATENTS IN URINALYSIS MARKET, 2023–2025
 
 
 
 
 
 
TABLE 26
KEY COMPANIES IMPLEMENTING AI IN URINALYSIS MARKET
 
 
 
 
 
 
TABLE 27
URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 28
KEY PRODUCTS IN URINALYSIS CONSUMABLES MARKET
 
 
 
 
 
 
TABLE 29
URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 30
URINALYSIS MARKET FOR CONSUMABLES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 31
NORTH AMERICA: URINALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 32
EUROPE: URINALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 33
ASIA PACIFIC: URINALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 34
LATIN AMERICA: URINALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 35
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 36
KEY PRODUCTS IN PREGNANCY & FERTILITY KITS MARKET
 
 
 
 
 
 
TABLE 37
URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 38
NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 39
EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 40
ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 42
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 43
KEY PRODUCTS IN URINALYSIS DIPSTICKS/URINE TEST STRIPS MARKET
 
 
 
 
 
 
TABLE 44
URINALYSIS MARKET FOR DIPSTICKS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
NORTH AMERICA: URINALYSIS MARKET FOR DIPSTICKS CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 46
EUROPE: URINALYSIS MARKET FOR DIPSTICKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
ASIA PACIFIC: URINALYSIS MARKET FOR DIPSTICKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 48
LATIN AMERICA: URINALYSIS MARKET FOR DIPSTICKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DIPSTICKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 50
KEY PRODUCTS IN URINALYSIS REAGENTS MARKET
 
 
 
 
 
 
TABLE 51
URINALYSIS MARKET FOR REAGENTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 52
NORTH AMERICA: URINALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
EUROPE: URINALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 54
ASIA PACIFIC: URINALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
LATIN AMERICA: URINALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 56
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
URINALYSIS MARKET FOR DISPOSABLES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 58
NORTH AMERICA: URINALYSIS MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 59
EUROPE: URINALYSIS MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 60
ASIA PACIFIC: URINALYSIS MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
LATIN AMERICA: URINALYSIS MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 62
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 63
KEY PRODUCTS IN URINALYSIS INSTRUMENTS MARKET
 
 
 
 
 
 
TABLE 64
URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
URINALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 66
NORTH AMERICA: URINALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
EUROPE: URINALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 68
ASIA PACIFIC: URINALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
LATIN AMERICA: URINALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
KEY PRODUCTS IN AUTOMATED URINE ANALYZERS MARKET
 
 
 
 
 
 
TABLE 72
AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
NORTH AMERICA: URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
EUROPE: URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 76
ASIA PACIFIC: URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
LATIN AMERICA: URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 78
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
KEY PRODUCTS IN INTEGRATED URINE ANALYZERS MARKET
 
 
 
 
 
 
TABLE 80
URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
NORTH AMERICA: URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 82
EUROPE: URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
ASIA PACIFIC: URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 84
LATIN AMERICA: URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 85
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 86
KEY PRODUCTS IN SEDIMENT URINE ANALYZERS MARKET
 
 
 
 
 
 
TABLE 87
SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 88
URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
NORTH AMERICA: URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 90
EUROPE: URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
ASIA PACIFIC: URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 92
LATIN AMERICA: URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 94
URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
NORTH AMERICA: URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 96
EUROPE: URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
ASIA PACIFIC: URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 98
LATIN AMERICA: URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 100
URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
NORTH AMERICA: URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
EUROPE: URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
ASIA PACIFIC: URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
LATIN AMERICA: URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 106
KEY PRODUCTS IN BIOCHEMICAL URINE ANALYZERS MARKET
 
 
 
 
 
 
TABLE 107
URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 110
ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
KEY PRODUCTS IN SEMI-AUTOMATED URINE ANALYZERS MARKET
 
 
 
 
 
 
TABLE 114
URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
NORTH AMERICA: URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 116
EUROPE: URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
ASIA PACIFIC: URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 118
LATIN AMERICA: URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
KEY PRODUCTS IN POINT-OF-CARE URINE ANALYZERS MARKET
 
 
 
 
 
 
TABLE 121
URINALYSIS MARKET FOR POINT-OF-CARE URINE ANALYZERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
NORTH AMERICA: URINALYSIS MARKET FOR POINT-OF-CARE URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
EUROPE: URINALYSIS MARKET FOR POINT-OF-CARE URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
ASIA PACIFIC: URINALYSIS MARKET FOR POINT-OF-CARE URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
LATIN AMERICA: URINALYSIS MARKET FOR POINT-OF-CARE URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR POINT-OF-CARE URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
NORTH AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
NORTH AMERICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
EUROPE: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
ASIA PACIFIC: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
LATIN AMERICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
TOTAL GERIATRIC POPULATION, 2030 VS. 2050 (%)
 
 
 
 
 
 
TABLE 142
URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
NORTH AMERICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
EUROPE: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
ASIA PACIFIC: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
LATIN AMERICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
ESTIMATED NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2024 VS. 2050 (IN MILLION)
 
 
 
 
 
 
TABLE 149
URINALYSIS MARKET FOR DIABETES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
NORTH AMERICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
EUROPE: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
ASIA PACIFIC: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
LATIN AMERICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 156
NORTH AMERICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
EUROPE: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
ASIA PACIFIC: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
LATIN AMERICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
NORTH AMERICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
EUROPE: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 164
ASIA PACIFIC: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
LATIN AMERICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 178
LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 180
URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 182
NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 184
ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 186
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 187
KEY PRODUCTS IN LABORATORY TESTS MARKET
 
 
 
 
 
 
TABLE 188
URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
NORTH AMERICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 190
EUROPE: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
ASIA PACIFIC: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 192
LATIN AMERICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 194
KEY PRODUCTS IN POC TESTS MARKET
 
 
 
 
 
 
TABLE 195
URINALYSIS MARKET FOR POC TESTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 196
NORTH AMERICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 197
EUROPE: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 198
ASIA PACIFIC: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
LATIN AMERICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 200
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 202
NORTH AMERICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
EUROPE: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 204
ASIA PACIFIC: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
LATIN AMERICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 206
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 207
URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 208
URINALYSIS MARKET FOR BIOCHEMICAL ASSAY, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL ASSAY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 210
EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL ASSAY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 211
ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL ASSAY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 212
LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL ASSAY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL ASSAY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 214
URINALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
NORTH AMERICA: URINALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 216
EUROPE: URINALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
ASIA PACIFIC: URINALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 218
LATIN AMERICA: URINALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 220
URINALYSIS MARKET FOR DIGITAL MICROSCOPY, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 221
NORTH AMERICA: URINALYSIS MARKET FOR DIGITAL MICROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 222
EUROPE: URINALYSIS MARKET FOR DIGITAL MICROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
ASIA PACIFIC: URINALYSIS MARKET FOR DIGITAL MICROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 224
LATIN AMERICA: URINALYSIS MARKET FOR DIGITAL MICROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DIGITAL MICROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 226
URINALYSIS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 227
NORTH AMERICA: URINALYSIS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 228
EUROPE: URINALYSIS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
ASIA PACIFIC: URINALYSIS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 230
LATIN AMERICA: URINALYSIS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 231
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 232
URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 233
URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 234
NORTH AMERICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 235
EUROPE: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 236
ASIA PACIFIC: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 237
LATIN AMERICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 238
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 239
URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 240
NORTH AMERICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 241
EUROPE: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 242
ASIA PACIFIC: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 243
LATIN AMERICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 244
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 245
URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 246
NORTH AMERICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 247
EUROPE: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 248
ASIA PACIFIC: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 249
LATIN AMERICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 250
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 251
URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 252
NORTH AMERICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 253
EUROPE: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 254
ASIA PACIFIC: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 255
LATIN AMERICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 256
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 257
URINALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 258
NORTH AMERICA: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 259
NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 260
NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 261
NORTH AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 262
NORTH AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 263
NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 264
NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 265
NORTH AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 266
NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 267
NORTH AMERICA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 268
NORTH AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 269
NORTH AMERICA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 270
NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 271
US LABORATORY-BASED URINALYSIS TEST VOLUME, 2024–2031 (IN MN)
 
 
 
 
 
 
TABLE 272
US: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 273
US: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 274
US: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 275
US: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 276
US: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 277
US: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 278
US: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 279
US: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 280
US: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 281
US: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 282
US: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 283
CANADA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 284
CANADA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 285
CANADA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 286
CANADA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 287
CANADA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 288
CANADA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 289
CANADA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 290
CANADA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 291
CANADA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 292
CANADA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 293
CANADA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 294
MACROECONOMIC INDICATORS FOR EUROPE
 
 
 
 
 
 
TABLE 295
EUROPE: URINALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 296
EUROPE: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 297
EUROPE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 298
EUROPE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 299
EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 300
EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 301
EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 302
EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 303
EUROPE: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 304
EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 305
EUROPE: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 306
EUROPE: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 307
GERMANY: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 308
GERMANY: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 309
GERMANY: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 310
GERMANY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 311
GERMANY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 312
GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 313
GERMANY: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 314
GERMANY: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 315
GERMANY: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 316
GERMANY: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 317
GERMANY: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 318
UK: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 319
UK: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 320
UK: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 321
UK: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 322
UK: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 323
UK: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 324
UK: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 325
UK: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 326
UK: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 327
UK: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 328
UK: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 329
FRANCE: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 330
FRANCE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 331
FRANCE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 332
FRANCE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 333
FRANCE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 334
FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 335
FRANCE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 336
FRANCE: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 337
FRANCE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 338
FRANCE: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 339
FRANCE: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 340
ITALY: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 341
ITALY: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 342
ITALY: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 343
ITALY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 344
ITALY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 345
ITALY: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 346
ITALY: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 347
ITALY: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 348
ITALY: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 349
ITALY: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 350
ITALY: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 351
SPAIN: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 352
SPAIN: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 353
SPAIN: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 354
SPAIN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 355
SPAIN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 356
SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 357
SPAIN: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 358
SPAIN: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 359
SPAIN: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 360
SPAIN: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 361
SPAIN: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 362
REST OF EUROPE: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 363
REST OF EUROPE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 364
REST OF EUROPE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 365
REST OF EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 366
REST OF EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 367
REST OF EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 368
REST OF EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 369
REST OF EUROPE: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 370
REST OF EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 371
REST OF EUROPE: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 372
REST OF EUROPE: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 373
MACROECONOMIC INDICATORS FOR ASIA PACIFIC
 
 
 
 
 
 
TABLE 374
ASIA PACIFIC: URINALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 375
ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 376
ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 377
ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 378
ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 379
ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 380
ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 381
ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 382
ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 383
ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 384
ASIA PACIFIC: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 385
ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 386
CHINA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 387
CHINA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 388
CHINA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 389
CHINA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 390
CHINA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 391
CHINA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 392
CHINA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 393
CHINA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 394
CHINA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 395
CHINA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 396
CHINA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 397
JAPAN: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 398
JAPAN: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 399
JAPAN: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 400
JAPAN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 401
JAPAN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 402
JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 403
JAPAN: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 404
JAPAN: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 405
JAPAN: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 406
JAPAN: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 407
JAPAN: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 408
INDIA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 409
INDIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 410
INDIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 411
INDIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 412
INDIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 413
INDIA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 414
INDIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 415
INDIA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 416
INDIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 417
INDIA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 418
INDIA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 419
AUSTRALIA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 420
AUSTRALIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 421
AUSTRALIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 422
AUSTRALIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 423
AUSTRALIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 424
AUSTRALIA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 425
AUSTRALIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 426
AUSTRALIA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 427
AUSTRALIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 428
AUSTRALIA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 429
AUSTRALIA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 430
SOUTH KOREA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 431
SOUTH KOREA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 432
SOUTH KOREA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 433
SOUTH KOREA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 434
SOUTH KOREA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 435
SOUTH KOREA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 436
SOUTH KOREA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 437
SOUTH KOREA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 438
SOUTH KOREA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 439
SOUTH KOREA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 440
SOUTH KOREA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 441
REST OF ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 442
REST OF ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 443
REST OF ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 444
REST OF ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 445
REST OF ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 446
REST OF ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 447
REST OF ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 448
REST OF ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 449
REST OF ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 450
REST OF ASIA PACIFIC: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 451
REST OF ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 452
MACROECONOMIC INDICATORS FOR LATIN AMERICA
 
 
 
 
 
 
TABLE 453
LATIN AMERICA: URINALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 454
LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 455
LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 456
LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 457
LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 458
LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 459
LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 460
LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 461
LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 462
LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 463
LATIN AMERICA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 464
LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 465
BRAZIL: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 466
BRAZIL: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 467
BRAZIL: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 468
BRAZIL: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 469
BRAZIL: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 470
BRAZIL: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 471
BRAZIL: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 472
BRAZIL: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 473
BRAZIL: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 474
BRAZIL: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 475
BRAZIL: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 476
MEXICO: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 477
MEXICO: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 478
MEXICO: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 479
MEXICO: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 480
MEXICO: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 481
MEXICO: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 482
MEXICO: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 483
MEXICO: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 484
MEXICO: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 485
MEXICO: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 486
MEXICO: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 487
REST OF LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 488
REST OF LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 489
REST OF LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 490
REST OF LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 491
REST OF LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 492
REST OF LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 493
REST OF LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 494
REST OF LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 495
REST OF LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 496
REST OF LATIN AMERICA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 497
REST OF LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 498
MACROECONOMIC INDICATORS FOR MIDDLE EAST & AFRICA
 
 
 
 
 
 
TABLE 499
MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 500
MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 501
MIDDLE EAST & AFRICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 502
MIDDLE EAST & AFRICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 503
MIDDLE EAST & AFRICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 504
MIDDLE EAST & AFRICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 505
MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 506
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 507
MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 508
MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 509
MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 510
MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 511
UAE: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 512
UAE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 513
UAE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 514
UAE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 515
UAE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 516
UAE: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 517
UAE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 518
UAE: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 519
UAE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 520
UAE: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 521
UAE: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 522
SAUDI ARABIA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 523
SAUDI ARABIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 524
SAUDI ARABIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 525
SAUDI ARABIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 526
SAUDI ARABIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 527
SAUDI ARABIA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 528
SAUDI ARABIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 529
SAUDI ARABIA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 530
SAUDI ARABIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 531
SAUDI ARABIA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 532
SAUDI ARABIA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 533
REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 534
REST OF THE MIDDLE EAST & AFRICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 535
REST OF THE MIDDLE EAST & AFRICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 536
EST OF THE MIDDLE EAST & AFRICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 537
REST OF THE MIDDLE EAST & AFRICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 538
REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 539
REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 540
REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 541
REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 542
REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 543
REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 544
OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN URINALYSIS MARKET, JANUARY 2023−JULY 2026
 
 
 
 
 
 
TABLE 545
URINALYSIS MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 546
URINALYSIS MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 547
URINALYSIS MARKET: PRODUCT FOOTPRINT
 
 
 
 
 
 
TABLE 548
URINALYSIS MARKET: APPLICATION FOOTPRINT
 
 
 
 
 
 
TABLE 549
URINALYSIS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
 
 
 
 
 
 
TABLE 550
URINALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY PRODUCT AND APPLICATION
 
 
 
 
 
 
TABLE 551
URINALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION
 
 
 
 
 
 
TABLE 552
URINALYSIS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023– JULY 2026
 
 
 
 
 
 
TABLE 553
URINALYSIS MARKET: DEALS, JANUARY 2023– JULY 2026
 
 
 
 
 
 
TABLE 554
URINALYSIS MARKET: EXPANSION, JANUARY 2023– JULY 2026
 
 
 
 
 
 
TABLE 555
SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 556
SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 557
SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026
 
 
 
 
 
 
TABLE 558
SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2023–JULY 2026
 
 
 
 
 
 
TABLE 559
SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2023–JULY 2026
 
 
 
 
 
 
TABLE 560
F. HOFFMANN-LA ROCHE LTD: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 561
F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 562
SYSMEX CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 563
SYSMEX CORPORATION: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 564
SYSMEX CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026
 
 
 
 
 
 
TABLE 565
SYSMEX CORPORATION: EXPANSIONS, JANUARY 2023–JULY 2026
 
 
 
 
 
 
TABLE 566
DANAHER CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 567
DANAHER CORPORATION: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 568
DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026
 
 
 
 
 
 
TABLE 569
DANAHER CORPORATION: DEALS, JANUARY 2023–JULY 2026
 
 
 
 
 
 
TABLE 570
ABBOTT: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 571
ABBOTT: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 572
CARDINAL HEALTH, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 573
CARDINAL HEALTH, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 574
CARDINAL HEALTH, INC.: EXPANSIONS, JANUARY 2023–JULY 2026
 
 
 
 
 
 
TABLE 575
WATERS CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 576
WATERS CORPORATION: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 577
WATERS CORPORATION: DEALS, JANUARY 2023–JULY 2026
 
 
 
 
 
 
TABLE 578
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 579
THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 580
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 581
BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 582
QUIDELORTHO CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 583
QUIDELORTHO CORPORATION: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 584
URINALYSIS MARKET: RISK ASSESSMENT
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
URINALYSIS MARKET SEGMENTATION
 
 
 
 
 
 
FIGURE 2
KEY INSIGHTS AND MARKET HIGHLIGHTS
 
 
 
 
 
 
FIGURE 3
GLOBAL URINALYSIS MARKET, 2024–2031
 
 
 
 
 
 
FIGURE 4
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN URINALYSIS MARKET, 2023–2025
 
 
 
 
 
 
FIGURE 5
DISRUPTIVE TRENDS IMPACTING GROWTH OF URINALYSIS MARKET
 
 
 
 
 
 
FIGURE 6
HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN URINALYSIS MARKET, 2025
 
 
 
 
 
 
FIGURE 7
ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 8
INCREASING PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH
 
 
 
 
 
 
FIGURE 9
CONSUMABLES SEGMENT TO DOMINATE URINALYSIS MARKET
 
 
 
 
 
 
FIGURE 10
BIOCHEMICAL TESTS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 11
DISEASE SCREENING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 12
BIOCHEMICAL ASSAY SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 13
DIAGNOSTIC LABORATORIES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 14
ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 15
URINALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 16
URINALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 17
URINALYSIS MARKET: SUPPLY CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 18
URINALYSIS MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 19
URINALYSIS MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 20
URINALYSIS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
FIGURE 21
NUMBER OF DEALS & FUNDING ACTIVITIES IN URINALYSIS MARKET
 
 
 
 
 
 
FIGURE 22
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
 
 
 
 
 
 
FIGURE 23
KEY BUYING CRITERIA, BY PRODUCT
 
 
 
 
 
 
FIGURE 24
PATENT ANALYSIS FOR URINALYSIS, JANUARY 2016–DECEMBER 2025
 
 
 
 
 
 
FIGURE 25
MARKET POTENTIAL OF AI IN URINALYSIS MARKET
 
 
 
 
 
 
FIGURE 26
NORTH AMERICA: URINALYSIS MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 27
ASIA PACIFIC: URINALYSIS MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 28
REVENUE ANALYSIS OF KEY PLAYERS IN URINALYSIS MARKET, 2023–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 29
URINALYSIS MARKET SHARE ANALYSIS, 2025 (GLOBAL)
 
 
 
 
 
 
FIGURE 30
URINALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 31
URINALYSIS MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 32
URINALYSIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 33
EV/EBITDA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 34
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 35
URINALYSIS MARKET: BRAND/PRODUCT COMPARISON FOR URINE ANALYZERS
 
 
 
 
 
 
FIGURE 36
SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 37
F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 38
SYSMEX CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 39
DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 40
ABBOTT: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 41
CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 42
WATERS CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 43
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 44
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 45
QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 46
URINALYSIS MARKET: RESEARCH DESIGN METHODOLOGY
 
 
 
 
 
 
FIGURE 47
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
 
 
FIGURE 48
BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
 
 
 
 
 
 
FIGURE 49
URINALYSIS MARKET: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 50
DATA TRIANGULATION METHODOLOGY
 
 
 
 
 
 

Methodology

The objective of this study is to analyze the key market dynamics, including drivers, opportunities, constraints, challenges, and strategies employed by key players. Developments within companies, such as acquisitions, product launches, expansions, agreements, and partnerships, will be tracked to assess the competitive landscape of the urinalysis market. This analysis will evaluate market players across various parameters within the broader categories of business and product strategy.

To estimate the market size, both top-down and bottom-up approaches were used. The market breakdown and data triangulation were used to determine the sizes of segments and subsegments.

The four steps involved in estimating the market size are:

Secondary Research

In the secondary research process, various secondary sources, including annual reports, press releases and investor presentations from companies, white papers, certified publications, articles by recognized authors, gold- and silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva), were consulted to identify and collect information for this study.

Primary Research

In the primary research process, interviews with sources from both the supply and demand sides were conducted to gather qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with key industry participants, subject-matter experts, C-level executives at key market players, and industry consultants to obtain and verify critical qualitative and quantitative information and to assess prospects.

Urinalysis Market Size, and Share

Note 1: Other designations include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

COMPANY NAME

DESIGNATION

Sysmex Corporation

Sales Manager

Thermo Fisher Scientific, Inc.

Sales Executive

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the urinalysis market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research.
  • The revenue generated by leading players operating in the urinalysis market was determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

The research methodology used to estimate the market size includes the following:

Urinalysis Market Top Down and Bottom Up Approach

Data Triangulation

After determining the overall market size using the process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.

Market Definition

Urinalysis is a procedure used to assess the appearance, concentration, and content of urine. It detects and helps manage various disorders, such as urinary tract infections, kidney diseases, diabetes, and other metabolic disorders. The primary urinalysis tests include biochemical and sediment analysis. In this report, we have also discussed pregnancy and fertility tests for urine analysis.

Key Stakeholders

  • Manufacturers and Distributors of Urinalysis Products
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Laboratories & Institutes
  • Research & Development (R&D) Companies
  • Government Associations
  • Venture Capitalists and Investors

Report Objectives

  • To define, segment, and forecast the urinalysis market by product, test type, application, technology, end user, and region
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market 
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
  • To study the impact of AI on the market, along with the macroeconomic outlook for each region

Available customizations:

MarketsandMarkets offers the following customizations for this market report.

Country Information

  • Additional country-level analysis of the urinalysis market

Company profiles

  • Additional five company profiles of players operating in the urinalysis market.

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the urinalysis market

 

Table of Contents

Methodology

 Request Customization Speak to Analyst
Speak to Analyst
Fact checked
Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Urinalysis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Urinalysis Market

logo

MnM Analyst

Jul, 2023

Below are the top 3 technological advancements in urinalysis market:
1. Automated Urine Analyzers: Automated urine analyzers are sophisticated machines that can rapidly and accurately analyze a urine sample. This technology allows for automated testing of multiple parameters in a single sample, eliminating the need for manual handling and improving the accuracy of results.
2. High-throughput Urine Testing: High-throughput urine testing technology uses robotic and automated systems to process a large number of urine samples at once, significantly reducing the time and cost of performing urinalysis.
3. Point-of-Care Urine Testing: Point-of-care urine testing technology allows for testing to be done quickly and easily in a clinical setting, without the need for a laboratory. This technology is particularly useful for rapid screening and diagnosis of urinary tract infections..

avtar

Jane

Jul, 2023

what is the technological advancement in urinalysis market?.

DMCA.com Protection Status
popup img